About Biocell Pharmaceuticals Private Limited
Data last updated:
Biocell Pharmaceuticals Private Limited is a private limited company based in Manimajra, Chandigarh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 29 August 2011 and has been in existence for over 15 years.
The company is registered with the Registrar of Companies (ROC), Chandigarh, under CIN U24232CH2011PTC033204. Its GSTIN is 04AAECB7827P1Z9 (Chandigarh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors Anurag Bhatia and Deepika Bhatia.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Scf No. 262 Ground Floor And Basement Motor Market, Manimajra, Chandigarh, India – 160101.
As per the financials filed for FY 2025, the company reported a revenue of ₹3.81 Cr, a growth of 2% compared to the previous year. For the same year it recorded a net profit of ₹13.85 Lakh (net margin 3.6%) and EBITDA of ₹22.11 Lakh (EBITDA margin 5.8%). Revenue has grown at a compounded annual rate (CAGR) of 4% over three years and 8% over five years.
The company is associated with 1 brand: Biocell Pharmaceuticals. As per MCA filings, the company has open charges of ₹4.05 Lakh on record. Court records list 1 case involving the company, including 1 filed by the company; 1 case is pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website biocellpharma.in.
Company details
Contact details
Biocell Pharmaceuticals Private Limited's registered office is in Manimajra, Chandigarh. Its website is biocellpharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressScf No. 262 Ground Floor And Basement Motor Market, Manimajra, Chandigarh, India – 160101
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Biocell Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Biocell Pharmaceuticals operates one associated brand: Biocell Pharmaceuticals. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and franchise services in India. | biocellpharma.in |
Business activity
The main business activity of Biocell Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Biocell Pharmaceuticals Private Limited, buy the company report.
Financials of Biocell Pharmaceuticals Private Limited
FY 2025 filings availableBiocell Pharmaceuticals Private Limited reported revenue of ₹3.81 Cr (up 2% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 2% growth in the latest year. EBITDA fell 2% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹22.11 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹13.85 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 5.8% | ||||
| Net Profit Margin | 3.6% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Biocell Pharmaceuticals Private Limited, buy the company report.
Board of directors of Biocell Pharmaceuticals Private Limited
Biocell Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anurag Bhatia Also directs: Biocordis Pharmaceuticals Private Limited | Director | 29 Aug 2011 | 15 Years 1 Months | Current |
| Deepika Bhatia Also directs: Biocordis Pharmaceuticals Private Limited | Director | 07 Feb 2025 | 1 Years 8 Months | Current |
Peer comparison
Biocell Pharmaceuticals Private Limited is compared with the 5 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Ambrosia Chemicals & Pharmaceuticals Private Limited | ₹3.82 Cr (FY 2023) | 80.0% | Nagpur, Maharashtra, India | |||
| Burgeon Health Series Private Limited | ₹3.82 Cr (FY 2025) | 89.0% | Chandigarh, India | |||
| Biocell Pharmaceuticals Private Limitedthis company | ₹3.81 Cr (FY 2025) | ₹13.85 Lakh | 3.6% | 2.0% | Manimajra, Chandigarh, India | |
| Ziffex Pharmaceuticals Private Limited | ₹3.8 Cr (FY 2024) | 48.0% | Sonipat, Haryana, India | |||
| Aarotax Pharmaceuticals Private Limited | ₹3.8 Cr (FY 2023) | 9.0% | Sanand, Gujarat, India | |||
| Nutraferon Private Limited | ₹3.79 Cr (FY 2025) | 104.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Biocell Pharmaceuticals Private Limited, buy the company report.
Auditor
Biocell Pharmaceuticals Private Limited is audited by S P BABUTA & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| S P BABUTA & ASSOCIATES | FY 2021 | 007657N |
Shareholding
The shareholding of Biocell Pharmaceuticals Private Limited is on record for 4 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2017 | FY 2016 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Biocell Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Aug 2021 | 100475100 | Hdfc Bank Limited | ₹4.05 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
Biocell Pharmaceuticals Private Limited has 1 court case on record: 1 filed by Biocell Pharmaceuticals. All case is pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 0 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Chandigarh | Cheque dishonour complaint | Filed by the company against Hooranpriya Ambha Pharma and 1 other | Pending |
To see the full case history of Biocell Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Biocell Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Biocell Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 04AAECB7827P1Z9 | Chandigarh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Biocell Pharmaceuticals Private Limited, buy the company report.
Recent activity
Biocell Pharmaceuticals Private Limited has 3 board changes on record since 2011: 2 appointments and 1 cessation. The latest: Bharat Bhushan Singh ceased to be Director on 24 Feb 2025.
Frequently asked questions
Biocell Pharmaceuticals is an active private limited company based in Manimajra, Chandigarh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 29 August 2011 (15+ years old) and is registered under CIN U24232CH2011PTC033204.
Biocell Pharmaceuticals has 2 current directors:
- Anurag Bhatia - Director
- Deepika Bhatia - Director
The latest financial statements of Biocell Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Biocell Pharmaceuticals is 04AAECB7827P1Z9, registered in Chandigarh.
The CIN (Corporate Identification Number) of Biocell Pharmaceuticals is U24232CH2011PTC033204. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Biocell Pharmaceuticals has 1 court case on record: 1 filed by the company. 1 is pending.
Biocell Pharmaceuticals was incorporated on 29 August 2011, making it 15+ years old. It is registered with the Registrar of Companies, Chandigarh.
The peers of Biocell Pharmaceuticals by revenue are Ambrosia Chemicals & Pharmaceuticals Private Limited, Burgeon Health Series Private Limited, Ziffex Pharmaceuticals Private Limited, Aarotax Pharmaceuticals Private Limited, Nutraferon Private Limited, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (wholesale trading).
Bharat Bhushan Singh ceased to be Director on 24 Feb 2025. Deepika Bhatia was appointed as Director on 07 Feb 2025. Anurag Bhatia was appointed as Director on 29 Aug 2011.
Biocell Pharmaceuticals can be reached through the website biocellpharma.in. Its registered office is in Manimajra, Chandigarh, India.
The registered office of Biocell Pharmaceuticals is at Scf No. 262 Ground Floor And Basement Motor Market, Manimajra, Chandigarh, India – 160101.